Key2Compliance Becomes a Trusted Partner of the Flemingsberg Science Foundation

Flemingsberg 2024-09-05

Today the Flemingsberg Science Foundation announces that Key2Compliance has become a Trusted Partner, entering into a strategic collaboration aimed at promoting and strengthening the development of ATMP (Advanced Therapy Medicinal Products) and the Life Science sector in Flemingsberg.

With the rapid development of ATMP in Flemingsberg, the foundation seeks to create a strong support network for individuals and companies within Life Science. Through this partnership with Key2Compliance, we are taking another significant step towards building a robust infrastructure for innovation and growth in the region.

“With ATMP-Flemingsberg, we aim to create the best possible conditions for the growth of ATMP companies in Sweden. This is, of course, best achieved through collaboration with others. That Key2Compliance is now joining as a partner in this effort is both exciting and important. I’m really looking forward to working together with Key2Compliance and also warmly welcome them as a new member at Innovation Station.”– Johnny Högberg, CEO of Flemingsberg Science Foundation.

As a Trusted Partner, Key2Compliance will offer tailored services, training, lectures, and events for the Flemingsberg Business Community. With their presence in Flemingsberg, they can efficiently and effectively address the specific needs of companies and organizations within the Life Science sector.

“We at Key2Compliance are proud and pleased to become a Trusted Partner of the Flemingsberg Science Foundation. By collaborating with the Flemingsberg Science Foundation, we have the opportunity to be an active and contributing part of Flemingsberg’s research-driven network within Life Science, especially ATMP. We are passionate about supporting innovative companies and organizations in both anticipating future regulatory challenges and contributing with knowledge and solutions that drive their success.” – Jan Hellqvist, CEO of Key2Compliance.

We hope that more will join us as Trusted Partners. If you are someone who can contribute to strengthening the innovation environment and business climate in Flemingsberg, don’t hesitate to get in touch!

NextCell Pharma

“Flemingsberg is exactly the right place for us thanks to its proximity to collaboration partners and the clinical research conducted at Karolinska University Hospital. Furthermore, it’s the right place for us to grow given how Flemingsberg as a whole is flourishing and developing,” says Mathias Svahn.

Sprint Bioscience

In Flemingsberg, there is an opportunity for us to grow and offer a good working environment for our employees. Here are the benefits of proximity to research at Karolinska Institutet and clinical research at Karolinska University Hospital. We are also attracted by the fact that the area represents innovation and looks forward with excitement to the upcoming development and that we, together with the other Life Science companies in the area, will be an important part of the new Flemingsberg.

Alfred Nobels Allé closed for traffic

Alfred Nobels allé will be shut down from September 11, 2019 due to district heating work. The street is closed for passage through Anatomy Road and entrance to the Forensic Psychiatric Clinic.

Previous 798081 Next